Health Sciences North Advances Cancer Care Through Clinical Trials
Key Insights
Health Sciences North (search) Research Institute (HSNRI) is making significant strides in cancer (search) treatment through clinical trials, offering patients access to cutting-edge therapies.
Ten open trials, ranging from academic studies to investigational drug trials, aim to improve overall survival and symptom management for cancer (search) patients in Sudbury.
A study on oral mucositis (search), a complication of radiation therapy, demonstrated the potential of new medications to alleviate pain and improve patients' ability to eat and drink.
Sudbury's Health Sciences North (search) Research Institute (HSNRI) is improving cancer (search) patient outcomes through cutting-edge clinical trials. These trials provide access to treatments not yet available on the market, according to Amanda Snyder, a clinical research study coordinator in cancer research at Health Sciences North. The institute currently has ten open trials, ranging from academic studies to radiation and investigational drug trials.
Access to Advanced Treatments
Snyder emphasized that these trials offer patients access to advanced treatments, potentially leading to better overall survival and improved symptom management. "What the patients are getting, you know, essentially are cutting-edge treatments … that just haven't come to market yet," she stated.
These trials are rigorously reviewed and approved by ethics boards, Health Canada, and the U.S. Food and Drug Administration (FDA), ensuring patient safety and ethical conduct.
Oral Mucositis Study
One notable study conducted in Sudbury focused on patients with oral mucositis (search), a painful complication of radiation therapy that causes mouth ulcers, making it difficult to eat or drink. The trial provided medication that allowed patients to eat and drink, reducing pain and the need for hospitalization. "It was kind of a dual purpose of the study, and it was actually really cool how the medication did benefit the patients in the long term,” Snyder noted.
FDA Monitoring and Impact
The success of the oral mucositis (search) study led to the FDA monitoring the results in Sudbury. Snyder mentioned that the FDA's presence underscored the significance of the research being conducted locally. "This was the first time the FDA actually came to our site to monitor the study." The positive outcomes observed in Sudbury highlight the importance of ongoing research and its potential to improve patient care.
Patient Support and Understanding
Snyder also highlighted the importance of patient support and understanding when participating in clinical trials. Recognizing that a cancer (search) diagnosis can be overwhelming, she emphasizes the need for clear communication and support to help patients understand the potential benefits of participating in a trial. Patients involved in clinical trials often receive one-on-one nursing care, ensuring they are well-supported throughout their treatment journey.